Mark E. Lobatto

3.0k total citations
24 papers, 1.6k citations indexed

About

Mark E. Lobatto is a scholar working on Biomaterials, Immunology and Cancer Research. According to data from OpenAlex, Mark E. Lobatto has authored 24 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Biomaterials, 10 papers in Immunology and 6 papers in Cancer Research. Recurrent topics in Mark E. Lobatto's work include Atherosclerosis and Cardiovascular Diseases (10 papers), Nanoparticle-Based Drug Delivery (10 papers) and Cardiovascular Disease and Adiposity (4 papers). Mark E. Lobatto is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (10 papers), Nanoparticle-Based Drug Delivery (10 papers) and Cardiovascular Disease and Adiposity (4 papers). Mark E. Lobatto collaborates with scholars based in Netherlands, United States and France. Mark E. Lobatto's co-authors include Willem J. M. Mulder, Zahi A. Fayad, Valentı́n Fuster, Claudia Calcagno, Edward A. Fisher, Ronald E. Gordon, Erik S.G. Stroes, Gert Storm, François Fay and David P. Cormode and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Nano Letters.

In The Last Decade

Mark E. Lobatto

23 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark E. Lobatto Netherlands 16 531 501 444 387 340 24 1.6k
Chase W. Kessinger United States 23 552 1.0× 533 1.1× 655 1.5× 118 0.3× 148 0.4× 39 1.8k
Esad Vucic United States 22 459 0.9× 474 0.9× 445 1.0× 411 1.1× 464 1.4× 35 2.3k
Vardan Amirbekian United States 12 266 0.5× 341 0.7× 235 0.5× 214 0.6× 343 1.0× 14 1.4k
Dengfeng Cheng China 24 410 0.8× 576 1.1× 740 1.7× 164 0.4× 143 0.4× 125 2.1k
Yongkang Gai China 25 362 0.7× 679 1.4× 624 1.4× 126 0.3× 203 0.6× 96 1.8k
Hisanori Kosuge Japan 25 167 0.3× 276 0.6× 460 1.0× 443 1.1× 280 0.8× 68 1.6k
Haokao Gao China 24 360 0.7× 399 0.8× 624 1.4× 94 0.2× 173 0.5× 46 1.7k
Deliang Fu China 28 370 0.7× 482 1.0× 994 2.2× 279 0.7× 471 1.4× 99 2.7k
Marta Truffi Italy 24 405 0.8× 394 0.8× 704 1.6× 155 0.4× 154 0.5× 69 1.7k
Tae Sup Lee South Korea 24 304 0.6× 464 0.9× 842 1.9× 188 0.5× 85 0.3× 81 2.0k

Countries citing papers authored by Mark E. Lobatto

Since Specialization
Citations

This map shows the geographic impact of Mark E. Lobatto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Lobatto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Lobatto more than expected).

Fields of papers citing papers by Mark E. Lobatto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Lobatto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Lobatto. The network helps show where Mark E. Lobatto may publish in the future.

Co-authorship network of co-authors of Mark E. Lobatto

This figure shows the co-authorship network connecting the top 25 collaborators of Mark E. Lobatto. A scholar is included among the top collaborators of Mark E. Lobatto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark E. Lobatto. Mark E. Lobatto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Delewi, Ronak, et al.. (2022). A Late Complication in a Surgically Corrected ALCAPA Patient. JACC Case Reports. 4(12). 704–705.
2.
Lobatto, Mark E., Tina Binderup, Philip M. Robson, et al.. (2019). Multimodal Positron Emission Tomography Imaging to Quantify Uptake of 89Zr-Labeled Liposomes in the Atherosclerotic Vessel Wall. Bioconjugate Chemistry. 31(2). 360–368. 27 indexed citations
3.
Senders, Max L., Xuchu Que, Young Seok Cho, et al.. (2018). PET/MR Imaging of Malondialdehyde-Acetaldehyde Epitopes With a Human Antibody Detects Clinically Relevant Atherothrombosis. Journal of the American College of Cardiology. 71(3). 321–335. 34 indexed citations
4.
Senders, Max L., Mark E. Lobatto, Olivier Lairez, et al.. (2018). Development and Multiparametric Evaluation of Experimental Atherosclerosis in Rabbits. Methods in molecular biology. 1816. 385–400. 2 indexed citations
5.
Pérez‐Medina, Carlos, Tina Binderup, Mark E. Lobatto, et al.. (2016). Multimodal PET imaging of high-density lipoprotein's trafficking in multiple atherosclerosis models. 57. 63–63. 1 indexed citations
6.
Lobatto, Mark E., Claudia Calcagno, Antoine Millon, et al.. (2015). Atherosclerotic Plaque Targeting Mechanism of Long-Circulating Nanoparticles Established by Multimodal Imaging. ACS Nano. 9(2). 1837–1847. 102 indexed citations
7.
Lobatto, Mark E., Claudia Calcagno, Maarten J. Otten, et al.. (2015). Pharmaceutical development and preclinical evaluation of a GMP-grade anti-inflammatory nanotherapy. Nanomedicine Nanotechnology Biology and Medicine. 11(5). 1133–1140. 36 indexed citations
8.
Valk, Fleur M. van der, Diederik F. van Wijk, Mark E. Lobatto, et al.. (2015). Prednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration. Nanomedicine Nanotechnology Biology and Medicine. 11(5). 1039–1046. 128 indexed citations
9.
Sánchez-Gaytán, Brenda L., François Fay, Mark E. Lobatto, et al.. (2015). HDL-Mimetic PLGA Nanoparticle To Target Atherosclerosis Plaque Macrophages. Bioconjugate Chemistry. 26(3). 443–451. 129 indexed citations
10.
Alaarg, Amr, Anouk A.J. Hamers, Miranda Versloot, et al.. (2015). Targeted liposomal drug delivery to inhibit atherosclerotic plaque inflammation. Atherosclerosis. 241(1). e87–e87. 4 indexed citations
11.
Wijk, Diederik F. van, Barbara Sjouke, Amparo L. Figueroa, et al.. (2014). Nonpharmacological Lipoprotein Apheresis Reduces Arterial Inflammation in Familial Hypercholesterolemia. Journal of the American College of Cardiology. 64(14). 1418–1426. 76 indexed citations
12.
Lobatto, Mark E., Claudia Calcagno, Josbert M. Metselaar, et al.. (2012). Imaging the Efficacy of Anti-Inflammatory Liposomes in a Rabbit Model of Atherosclerosis by Non-Invasive Imaging. Methods in enzymology on CD-ROM/Methods in enzymology. 508. 211–228. 22 indexed citations
13.
Bini, Jason, Philip M. Robson, Claudia Calcagno, et al.. (2012). Radial k-space acquisition improves robustness of MR-based attenuation maps for MR/PET quantification in an animal imaging study of the abdomen. 34. 1–6. 1 indexed citations
14.
Duivenvoorden, Raphaël, David Izquierdo‐Garcia, David P. Cormode, et al.. (2011). Abstract 9601: A Statin-Loaded Nanotherapy Increases Anti-Inflammatory Effects of Statin on Atherosclerosis. Circulation. 124(suppl_21). 2 indexed citations
15.
Klink, Ahmed, Beatriz Herránz, Mark E. Lobatto, et al.. (2011). In Vivo Characterization of a New Abdominal Aortic Aneurysm Mouse Model With Conventional and Molecular Magnetic Resonance Imaging. Journal of the American College of Cardiology. 58(24). 2522–2530. 75 indexed citations
16.
Lobatto, Mark E., Valentı́n Fuster, Zahi A. Fayad, & Willem J. M. Mulder. (2011). Perspectives and opportunities for nanomedicine in the management of atherosclerosis. Nature Reviews Drug Discovery. 10(11). 835–852. 331 indexed citations
17.
Lobatto, Mark E., Valentı́n Fuster, Zahi A. Fayad, & Willem J. M. Mulder. (2011). Erratum: Perspectives and opportunities for nanomedicine in the management of atherosclerosis. Nature Reviews Drug Discovery. 10(12). 963–963. 6 indexed citations
18.
Lobatto, Mark E., Zahi A. Fayad, S. Silvera, et al.. (2010). Multimodal Clinical Imaging To Longitudinally Assess a Nanomedical Anti-Inflammatory Treatment in Experimental Atherosclerosis. Molecular Pharmaceutics. 7(6). 2020–2029. 128 indexed citations
19.
Mulder, Willem J. M., David P. Cormode, Sjoerd Hak, et al.. (2008). Multimodality nanotracers for cardiovascular applications. Nature Clinical Practice Cardiovascular Medicine. 5(S2). S103–S111. 33 indexed citations
20.
Cormode, David P., Torjus Skajaa, Matti M. van Schooneveld, et al.. (2008). Nanocrystal Core High-Density Lipoproteins: A Multimodality Contrast Agent Platform. Nano Letters. 8(11). 3715–3723. 265 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chase W. Kessinger Breakdown of academic impact, for papers by Esad Vucic Breakdown of academic impact, for papers by Vardan Amirbekian Breakdown of academic impact, for papers by Dengfeng Cheng Breakdown of academic impact, for papers by Yongkang Gai Breakdown of academic impact, for papers by Hisanori Kosuge Breakdown of academic impact, for papers by Haokao Gao Breakdown of academic impact, for papers by Deliang Fu Breakdown of academic impact, for papers by Marta Truffi Breakdown of academic impact, for papers by Tae Sup Lee
Rankless by CCL
2026